Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates.
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis / Q000276:immunology*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D002464:Cell Migration Inhibition; D002633:Chemotaxis; D002648:Child; D017977:Deltaretrovirus / Q000276:immunology*; D006098:Granulocytes / Q000276:immunology*; D015483:HIV Antibodies; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D008297:Male
D000914:Antibodies, Viral; D001779:Blood Coagulation Factors; D015483:HIV Antibodies